Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
15,392,157
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
15,298,947
-
Shares change
-
-90,401
-
Total reported value, excl. options
-
$265,156,048
-
Value change
-
-$165,307
-
Put/Call ratio
-
52%
-
Number of buys
-
38
-
Number of sells
-
36
-
Price
-
$17.33
Institutional Holders of Neurogene Inc. - Common Stock (NGNE) as of Q3 2025
As of 30 Sep 2025 Neurogene Inc. - Common Stock (NGNE) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,298,947 shares of stock of the company.
Largest 10 holders included SAMSARA BIOCAPITAL, LLC, RTW INVESTMENTS, LP, Redmile Group, LLC, Casdin Capital, LLC, EcoR1 Capital, LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc., Balyasny Asset Management L.P., TORONTO DOMINION BANK, and VANGUARD GROUP INC.
This table shows 87 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.